Maximus MMS Clinical Services — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maximus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Maximus’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maximus's clinical services — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maximus's clinical services — revenue?
- Maximus (MMS) reported clinical services — revenue of $530.81M in Q1 2026.
- How has Maximus's clinical services — revenue changed year-over-year?
- Maximus's clinical services — revenue increased by 5.3% year-over-year, from $503.96M to $530.81M.
- What is the long-term trend for Maximus's clinical services — revenue?
- Over 4 years (2021 to 2025), Maximus's clinical services — revenue has grown at a 31.6% compound annual growth rate (CAGR), from $699.42M to $2.1B.
- What does clinical services — revenue mean?
- This metric represents the total gross income generated specifically from the Clinical Services business segment. It reflects the scale and market demand for the company's clinical operations, including health assessments and related professional services. Tracking this revenue stream helps investors evaluate the growth trajectory and relative contribution of the clinical division to the overall corporate top-line performance.